- Home
- A-Z Publications
- Current Medicinal Chemistry
- Fast Track Listing
Current Medicinal Chemistry - Online First
Description text for Online First listing goes here...
140
results
41 - 60 of 140 results
-
-
Advanced Targeted Therapy for Colorectal Cancer with Lipid Nanoparticles
Authors: Pawan Kedar, Sankha Bhattacharya, Preeti Sakore and Bhupendra G. PrajapatiAvailable online: 16 January 2025More LessTargeted therapy for colorectal cancer (CRC) appears to have great potential with lipid nanoparticles (LNPs). The advances in LNP-based techniques, such as liposomes, exosomes, micelles, solid lipid nanoparticles (SLNs), nano-cubosomes, and plant-derived LNPs (PDLNPs), are explored in detail in this thorough review. Every platform provides distinct advantages: liposomes enable precise drug release and impro Read More
-
-
-
Poly Lactic Co-glycolic Acid d-α-tocopheryl Polyethylene Glycol 1000 Succinate Fabricated Polyethylene Glycol Hybrid Nanoparticles of Imatinib Mesylate for the Treatment of Glioblastoma Multiforme
Authors: Sankha Bhattacharya, Prafull Shinde, Amit Page and Bhupendra G. PrajapatiAvailable online: 14 January 2025More LessAims This study aimed to develop Imatinib Mesylate (IMT)-loaded Poly Lactic-co-Glycolic Acid (PLGA)-D-α-tocopheryl polyethylene glycol succinate (TPGS)- Polyethylene glycol (PEG) hybrid nanoparticles (CSLHNPs) with optimized physicochemical properties for targeted delivery to glioblastoma multiforme. Background Glioblastoma multiforme (GBM) is the most destructive type of brain tumor with several complications. Currentl Read More
-
-
-
Experimental Research Progress of mPGES-1 Inhibitor 2,5-dimethylcelecoxib in Various Diseases
Authors: Zhanfei Chen, Rong Chen, Laiping Wang, Zihao Yu, Weitong Chen, Hua Lin, Liumin Yu, Jinqiu Li, Zhonghui Chen, Jianlin Shen and Nanhong TangAvailable online: 14 January 2025More LessProstaglandin E2 (PGE2) plays a crucial role in inflammation. Non-steroidal anti-inflammatory medications are commonly utilized to alleviate pain and address inflammation by blocking the production of PGE2 and cyclooxygenase (COX). However, selective inhibition of COX can easily lead to a series of risks for cardiovascular diseases. Hence, it is imperative to discover safer and more efficient targets for reducing inflammation. Read More
-
-
-
A Promising Druggable Target for Translational Therapy of Ovarian Cancer: A Molecular Profiling of Therapeutic Innovations, Extracellular Vesicle Acquired Resistance, and Signaling Pathways
Available online: 14 January 2025More LessOvarian cancer (OC) ranks as the fifth leading cause of cancer-related deaths in the United States, posing a significant threat to female health. Late-stage diagnoses, driven by elusive symptoms often masquerading as gastrointestinal issues, contribute to a concerning 70% of cases being identified in advanced stages. While early-stage OC brags a 90% cure rate, progression involving pelvic organs or extending beyond the Read More
-
-
-
Ginsenoside Rg3 in Cancer Research: Current Trends and Future Prospects - A Review
Available online: 14 January 2025More LessCancer is one of the most devastating illnesses in the world, impacting millions of individuals every year. Despite various therapies, the final effect is unsatisfactory. Chemotherapy currently dominates as the primary option of treatment. However, its severe adverse effects, limited efficacy, and resistance to drugs undermine its potential. Growing evidence suggests that ginsenoside Rg3, a natural compound obtained from the gi Read More
-
-
-
Novel Strategies for the Treatment of Lung Cancer: An In-depth Analysis of the Use of Immunotherapy, Precision Medicine, and Artificial Intelligence to Improve Prognoses
Authors: Pawan Kedar, Sankha Bhattacharya, Abhishek Kanugo and Bhupendra G. PrajapatiAvailable online: 14 January 2025More LessTherapeutic hurdles persist in the fight against lung cancer, although it is a leading cause of cancer-related deaths worldwide. Results are still not up to par, even with the best efforts of conventional medicine, thus new avenues of investigation are required. Examining how immunotherapy, precision medicine, and AI are being used to manage lung cancer, this review shows how these tools can change the game for patients Read More
-
-
-
Theoretical Modeling of the Interactions of CoFe2O4-BaTiO3 Magnetoelectric Nanoparticles with Cancer and Healthy Cells
Authors: Gençay Sevim, Gizem Değer and Gülay BüyükköroğluAvailable online: 14 January 2025More LessIntroduction The effectiveness of pharmaceutical treatment methods is vital in cancer treatment. In this context, various targeted drug delivery systems are being developed to minimize or eliminate existing deficiencies and harms. This study aimed to model the interaction of MEN-based drug-targeting systems with cancer cells and determine the properties of interacting MENs. Methods Magnetoelectric Nanostructures (M Read More
-
-
-
Current Perspectives of Diabetic Dyslipidemia and Treatment Modalities
By Gamze AkkusAvailable online: 13 January 2025More LessIntroduction Diabetes mellitus is associated with an increased risk of atherosclerosis related to dyslipidemia. Although the terms hyperlipidemia and Diabetes Mellitus (DM) or diabetic dyslipidemia are interrelated to each other, these two conditions have some differences. Aim This study aimed to highlight possible mechanisms of hyperlipidemia and/or dyslipidemia in diabetic patients, which can be treated with available and newer Read More
-
-
-
Aptamers as a Potential Therapeutic and Screening Molecule for Oral Cancer
Available online: 10 January 2025More Less
-
-
-
Design, Synthesis, Biological Evaluation and Docking Studies of 2-hydroxy-4-benzyloxy Chalcone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
Authors: Wei Li, Jing Huang, Zhixin Chen, Dan Zhang, Lin He, Yan Guo, Lei Zhong, Chenwu Yang, Chunyan Yang, Mei Zeng, Jiang Zhu and Zhongcheng CaoAvailable online: 09 January 2025More LessBackground Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder, but no drugs can cure this disease. Chalcones possess good antioxidant activity, anti-neuroinflammatory activity, neuroprotective effects, inhibitory effects on Aβ aggregation, and Aβ disaggregation ability. Therefore, chalcones are ideal lead compounds, and the discovery of novel anti-AD agent-based chalcones is necessary. Methods Read More
-
-
-
Structural Modifications and Prospects of Histone Deacetylase (HDAC) Inhibitors in Cancer
Authors: Yu Chen, Jiahong Su, Sha Li, Feier Chen, Yan Zhang, Xingyue Wang, Yinping Zhang, Xiang Wang, Zijun Yuan, Siqi Ren, Xinyu He, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Shuai Deng, Jing Shen and Zhangang XiaoAvailable online: 09 January 2025More LessHistone deacetylases (HDACs) play a crucial role in the regulation of cancer progression and have emerged as key targets for antitumor therapy. Histone Deacetylase Inhibitors (HDACis) effectively suppress tumor cell proliferation, induce apoptosis, and cause cell cycle arrest, demonstrating broad-spectrum antitumor activity. This article primarily focuses on enhancing the selectivity of HDACis through structural modification u Read More
-
-
-
A Review on Branched-Chain Amino Acid Aminotransferase (BCAT) Inhibitors: Current Status, Challenges and Perspectives
Authors: Xiansheng Zhang, Xinyuan Zhu, Yong Li, Yan Li, Wen Luo, Maaz Khan, Jiamin Pan, Hong Pan, Hua Xie and Guilong ZhaoAvailable online: 08 January 2025More LessBranched-chain amino acids (BCAAs) are essential amino acids for humans and play an indispensable role in many physiological and pathological processes. Branched-chain amino acid aminotransferase (BCAT) is a key enzyme that catalyzes the metabolism of BCAAs. BCAT is upregulated in many cancers and implicated in the development and progress of some other diseases, such as metabolic and neurological diseases; an Read More
-
-
-
RNA Modification and Digestive Tract Tumors: A Review
Authors: Yafeng Liu, Shujun Zhang, Kaijie Liu, Xinyu Gu and Xinjun HuAvailable online: 08 January 2025More LessGastrointestinal tumors, including colorectal and liver cancer, are among the most prevalent and lethal solid tumors. These malignancies are characterized by worsening prognoses and increasing incidence rates. Traditional therapeutic approaches often prove ineffective. Recent advancements in high-throughput sequencing and sophisticated RNA modification detection technologies have uncovered numerous RN Read More
-
-
-
FDA Approves Inavolisib Combo for PIK3CA-Mutated, HR+ Breast Cancer
By Jinwei ZhangAvailable online: 08 January 2025More Less
-
-
-
Therapeutic Effects of Tea Polyphenols on Renal Damage Induced by High Uric Acid
Authors: Lingjuan Liu, Lanjun Shuai, Siyi He, Wei Xiang and Xiaojie HeAvailable online: 07 January 2025More LessBackground Hyperuricemia (HUA) is a condition characterized by excessive uric acid production and/or inadequate uric acid excretion due to abnormal purine metabolism in the human body. Uric acid deposits resulting from HUA can lead to complications such as renal damage. Currently, drugs used to treat HUA lack specificity and often come with specific toxic side effects. Objective This study aimed to investigate the ren Read More
-
-
-
Exploring Natural Analgesics for Chronic Pain Management: Cannabinoids and other Phytoconstituents
Available online: 06 January 2025More LessChronic pain lasting more than three months or persisting after normal healing is a significant global health issue. In a healthcare system, it is crucial to ensure proper chronic pain management. Traditional pharmacological and non-pharmacological pain management techniques may not fully meet the requirements of physicians regarding effectiveness and safety. Therefore, researchers are exploring natural analgesics. Pl Read More
-
-
-
Gold Nanoparticles and Chitosan as Innovative Compounds in Medicine and Cosmetology: A Review of Current Applications
Available online: 06 January 2025More LessThe medical and cosmetic industries have developed in recent years, and there has been a growing demand for new materials. Gold nanoparticles (Au NPs) and chitosan (CS) have been known and used for many years. Unfortunately, despite their numerous advantages and possible applications, such materials may possess certain disadvantages and limitations that constitute a problem in medical or cosmetic applica Read More
-
-
-
The Interplay of Diet, Genome, Metabolome, and Gut Microbiome in Cardiovascular Disease: A Narrative Review
Authors: Manije Darooghegi Mofrad, Seoeun Ahn and Ock K. ChunAvailable online: 06 January 2025More LessIntroduction/Objective The responsiveness to dietary interventions is influenced by complex, multifactorial interactions among genetics, diet, lifestyle, gut microbiome, environmental factors, and clinical characteristics, such as the metabolic phenotype. Detailed metabolic and microbial phenotyping using large human datasets is essential for better understanding the link between diet, the gut microbiome, and host meta Read More
-
-
-
An Azomethine Derivative, 1-(4-nitrophenyl)-N-phenylmethanimine (BCS2) Ameliorated 7,12-dimethylbenz(a)anthracene-induced Mammary Carcinoma through Nrf2-Keap1-HO-1 Pathway
Authors: Reetuparna Acharya, Pran Kishore Deb and Shakti Prasad PattanayakAvailable online: 06 January 2025More LessAims The aim of this study is the evaluation of an Azomethine derivative, BCS2, for its antioxidant and anti-tumor activities against mammary carcinoma through the Nrf2-Keap1-HO-1 pathway. Background The global prevalence of breast cancer is rising at an alarming rate. The facilitation of abnormal cell proliferation in mammary carcinoma occurs due to the disruption of signaling pathways that balance pro- and antioxida Read More
-
-
-
Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins
Available online: 03 January 2025More LessCovalent inhibitors play a pivotal role in the development of pharmaceutical therapies, as they form stable, irreversible bonds with target biomolecules, leading to prolonged therapeutic effects and enhanced efficacy. Since covalent inhibitors first appeared in the late 1800s, the field has become innovative rapidly, and covalent inhibitors now account for around 30% of all marketed therapeutics. The severe acute resp Read More
-